Amniocentesis Needle Market

Global Amniocentesis Needle Market Size, Share & Trends Analysis Report By Procedure, By End-use, By Type (100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm), By Regional Outlook and Forecast, 2023 - 2030

Report Id: KBV-20666 Publication Date: March-2024 Number of Pages: 226
2022
USD 171 Million
2030
USD 283.8 Million
CAGR
6.7%
Historical Data
2019 to 2021

“Global Amniocentesis Needle Market to reach a market value of USD 283.8 Million by 2030 growing at a CAGR of 6.7%”

Analysis of Market Size & Trends

The Global Amniocentesis Needle Market size is expected to reach $283.8 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period.

As awareness of prenatal care and genetic testing grows and healthcare infrastructure improves, an increasing number of pregnant females in the Asia Pacific region are requesting access to advanced prenatal diagnostic services, such as amniocentesis. Consequently, the Asia pacific region would acquire nearly 28% of the total market share by 2030. Improved access to healthcare facilities and prenatal care services enables individuals to undergo comprehensive prenatal screening and diagnostic procedures to assess fetal health and detect genetic abnormalities.

Amniocentesis Needle Market Size - Global Opportunities and Trends Analysis Report 2019-2030

Genetic disorders are becoming more prevalent due to various factors, including environmental factors, lifestyle changes, and increased exposure to mutagens. Moreover, advances in medical technology have made amniocentesis procedures safer, more accurate, and less invasive, thereby increasing its acceptance among pregnant individuals. Therefore, the rising incidence of genetic disorders is driving the growth of the market. Additionally, Government initiatives often aim to make prenatal screening and diagnostic procedures more accessible and affordable to pregnant individuals. Furthermore, governments often regulate the healthcare industry to ensure the safety and efficacy of medical devices and procedures. Therefore, increasing government initiatives and policies are driving the market's growth.

Moreover, during the height of the pandemic, many healthcare facilities faced disruptions in their normal operations. Non-urgent medical procedures, including some prenatal diagnostic tests like amniocentesis, were postponed or canceled to prioritize resources for COVID-19 patients. However, the market exhibited resilience and adaptability in the face of the obstacles presented by the pandemic. Manufacturers and healthcare providers implemented innovative solutions to address supply chain disruptions, enhance safety protocols, and prioritize patient care. Thus, the COVID-19 pandemic moderately impacted the market.

However, to acquire an amniotic fluid sample for genetic testing, amniocentesis requires the insertion of a catheter through the lining of the abdomen and into the amniotic sac. Moreover, amniocentesis carries a risk of infection, albeit low, due to the introduction of a foreign object (the needle) into the amniotic sac. Therefore, the risk of procedure-related complications is hampering the growth of the market.

Driving and Restraining Factors
Amniocentesis Needle Market
  • Rising incidence of genetic disorders
  • Increasing government initiatives and policies
  • Ongoing advancements in healthcare technology
  • Risk of procedure-related complications
  • High cost of procedure and testing
  • Expansion of prenatal screening programs
  • Increasing integration with genetic counseling services

By Procedure Analysis

On the basis of procedure, the market is segmented into amniocentesis procedures, amnioreduction procedures, fetal blood transfusion, amnioinfusion procedures, and cordocentesis procedure. In 2022, the fetal blood transfusion segment attained 27% revenue share in the market. Fetal anemia, distinguished by an inadequate quantity of red blood cells in the fetus, may arise from many causes, including alloimmune disorders or genetic anomalies. The incidence of fetal anemia may be increasing due to factors such as changes in maternal-fetal blood group incompatibilities, maternal health conditions, and environmental factors, driving the need for fetal blood transfusions.

By End-use Analysis

Based on end-use, the market is categorized into hospitals, diagnostics centers, clinics, and others. The clinics segment witnessed a 20% revenue share in the market in 2022. Clinics, especially those specializing in women's health and reproductive medicine, provide accessible and convenient healthcare services for pregnant individuals seeking prenatal screening and diagnostic procedures, including amniocentesis. Most clinics are often located in community settings, making them easily accessible to patients seeking comprehensive prenatal care.

Amniocentesis Needle Market Share and Industry Analysis Report 2022

By Type Analysis

Based on type, the market is divided into 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The smaller than 100 mm segment attained a 18% revenue share in the market in 2022. and tissue damage associated with larger needle sizes. Smaller needles enhance procedural safety and reduce the likelihood of adverse events during amniocentesis procedures by minimizing tissue trauma and needle deflection, improving patient outcomes and procedural success rates.

Free Valuable Insights: Global Amniocentesis Needle Market size to reach USD 283.8 Million by 2030

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 35% revenue share in the market in 2022. North America has witnessed a trend of increasing maternal age, with more women choosing to delay childbirth until later in life. Increased maternal age is correlated with a heightened likelihood of chromosomal defects and genetic disorders developing in fetuses; consequently, prenatal diagnostic procedures, including amniocentesis, are in greater demand as they evaluate the health and genetic status of the fetus.

Amniocentesis Needle Market Report Coverage
Report Attribute Details
Market size value in 2022 USD 171 Million
Market size forecast in 2030 USD 283.8 Million
Base Year 2022
Historical Period 2019 to 2021
Forecast Period 2023 to 2030
Revenue Growth Rate CAGR of 6.7% from 2023 to 2030
Number of Pages 226
Number of Tables 378
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives
Segments covered Procedure, Type, End-Use, Region
Country scope
  • North America (US, Canada, Mexico, and Rest of North America)
  • Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific)
  • LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)
Companies Included BIOPSYBELL S.R.L., Cook Medical, Inc. (Cook Group), Ri.Mos. Srl, CooperSurgical, Inc. (The Cooper Companies, Inc.), Rocket Medical plc (Röko AB), Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED), Moller Medical GmbH (Centrotec SE) and Becton, Dickinson and Company
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • BIOPSYBELL S.R.L.
  • Cook Medical, Inc. (Cook Group)
  • Ri.Mos. Srl
  • CooperSurgical, Inc. (The Cooper Companies, Inc.)
  • Rocket Medical plc (Röko AB)
  • Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
  • Moller Medical GmbH (Centrotec SE)
  • Becton, Dickinson and Company

Amniocentesis Needle Market Report Segmentation

By Procedure

  • Amniocentesis Procedures
  • Fetal Blood Transfusion
  • Amnioreduction Procedures
  • Amnioinfusion Procedure
  • Cordocentesis Procedure

By End-use

  • Hospitals
  • Diagnostics centers
  • Clinics
  • Others

By Type

  • 100 to 150 mm
  • Larger Than 150 mm
  • Smaller Than 100 mm

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Frequently Asked Questions About This Report

This Market size is expected to reach $283.8 million by 2030.

Rising incidence of genetic disorders are driving the Market in coming years, however, Risk of procedure-related complications restraints the growth of the Market.

BIOPSYBELL S.R.L., Cook Medical, Inc. (Cook Group), Ri.Mos. Srl, CooperSurgical, Inc. (The Cooper Companies, Inc.), Rocket Medical plc (Röko AB), Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED), Moller Medical GmbH (Centrotec SE) and Becton, Dickinson and Company

The expected CAGR of this Market is 6.7% from 2023 to 2030.

The Hospitals segment led the Market, by End-use in 2022; thereby, achieving a market value of $118 million by 2030.

The North America region dominated the Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $95.7 million by 2030.

HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo